195 related articles for article (PubMed ID: 25500455)
1. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
[TBL] [Abstract][Full Text] [Related]
2. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
[TBL] [Abstract][Full Text] [Related]
5. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C
Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409
[TBL] [Abstract][Full Text] [Related]
6. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
8. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and outcome of patients with small cell neuroendocrine carcinoma of the uterine cervix: case series and literature review.
Wang Y; Mei K; Xiang MF; Li JM; Xie RM
Eur J Gynaecol Oncol; 2013; 34(4):307-10. PubMed ID: 24020135
[TBL] [Abstract][Full Text] [Related]
10. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
12. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease.
McCann GA; Boutsicaris CE; Preston MM; Backes FJ; Eisenhauer EL; Fowler JM; Cohn DE; Copeland LJ; Salani R; O'Malley DM
Gynecol Oncol; 2013 Apr; 129(1):135-9. PubMed ID: 23357610
[TBL] [Abstract][Full Text] [Related]
15. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients.
Cohen JG; Kapp DS; Shin JY; Urban R; Sherman AE; Chen LM; Osann K; Chan JK
Am J Obstet Gynecol; 2010 Oct; 203(4):347.e1-6. PubMed ID: 20579961
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic characteristics of eight patients with small cell carcinoma of the cervix].
Cheng M; Wu LY; Bai P; Zhang R; Zheng S
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):189-92. PubMed ID: 18788567
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
19. [Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature].
Bellefqih S; Khalil J; Mezouri I; Kebdani T; Benjaafar N
Cancer Radiother; 2014 Jun; 18(3):201-7. PubMed ID: 24656987
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for small cell neuroendocrine carcinoma of the uterine cervix: an institutional experience.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Chandacham A; Sukpan K; Patumanond J
Int J Gynecol Cancer; 2014 Feb; 24(2):272-9. PubMed ID: 24401981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
